Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | XDH | P47989 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5634506 | 1.00 | ALDH1A3 (0.66) | ALDH1A3ALDH1A1KDM4EMAPTPARP10 | |
| SCHEMBL6969022 | 0.93 | ALDH1A3 (0.61) | ALDH1A3ALDH1A1KDM4EMAPTPARP10 | |
| SCHEMBL6969015 | 0.93 | ALDH1A3 (0.61) | ALDH1A3ALDH1A1KDM4EMAPTPARP10 | |
| SCHEMBL30384506 | 0.85 | ALDH1A3 (0.47) | ALDH1A3ALDH1A1KDM4EMAPTPARP10 | |
| SCHEMBL20024678 | 0.83 | ALDH1A3 (0.68) | ALDH1A3KDM4EPARP10LMNATRPA1 | |
| SCHEMBL16963585 | 0.81 | DRD1 (0.59) | ALDH1A3ALDH1A1KDM4EMAPTLMNA | |
| SCHEMBL16963584 | 0.81 | DRD1 (0.59) | ALDH1A3ALDH1A1KDM4EMAPTLMNA | |
| SCHEMBL384361 | 0.79 | ALDH1A3 (1.00) | ALDH1A3ALDH1A1KDM4EMAPTPARP10 | |
| SCHEMBL9111858 | 0.79 | ALDH1A3 (0.53) | ALDH1A3ALDH1A1KDM4EPARP10LMNA | |
| SCHEMBL2470272 | 0.79 | APP (0.57) | ALDH1A3ALDH1A1KDM4EMAPTPARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108558851-B | Coumarin-oxazole-ethylene type alpha-glucosidase inhibitor and preparation method and application thereof | 贵州医科大学 | 2021-03-05 | — | — | CN | disclosed |
| US-8558012-B2 | 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same | NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2013-10-15 | — | — | US | disclosed |
| US-20110319637-A1 | 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME | NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2011-12-29 | — | — | US | disclosed |
| US-7262296-B2 | Substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-28 | — | — | US | disclosed |
| US-7262296-B2 | Substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-28 | — | — | US | disclosed |
| US-7262296-B2 | Substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-28 | — | — | US | disclosed |
| US-7057040-B2 | Substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-06-06 | — | — | US | disclosed |
| US-20060094874-A1 | Novel substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2006-05-04 | — | — | US | disclosed |
| EP-0783496-B9 | THIAZOLIDINEDIONE DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-20030161860-A1 | Novel substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-08-28 | — | — | US | disclosed |
| EP-0783496-B1 | THIAZOLIDINEDIONE DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6147099-A | USEFUL AS ANTI-DIABETICS OR HYPOLIPIDEMIC AGENTS | TAKEDA CHEMICAL INDUSTRIES, INC. (JP) | 2000-11-14 | — | — | US | disclosed |
| US-5972970-A | COMPOUNDS SUCH AS 5-(3-(2-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL) ETHOXYL-5-PYRIDYL)PROPYL)-2,4-OXAZOLIDINEDIONE; ADMINISTERING TO TREAT A MAMMAL SUFFERING FROM DIABETES OR HYPERLIPIDEMIA | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| US-5965589-A | AN ACTIVE MATERIAL HAVING HYPOGLYCEMIC ACTIVITY AND BLOOD LIPID LOWERING ACTIVITY, FOR USE AS AN ANTIDIABETIC AGENT | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-10-12 | — | — | US | disclosed |
| EP-0612743-B1 | Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-09-10 | — | — | EP | disclosed |
| US-5665748-A | ANTIDIABETIC, HYPOLIPIDEMIC AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-09-09 | — | — | US | disclosed |
| EP-0783496-A1 | THIAZOLIDINEDIONE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1997-07-16 | — | — | EP | disclosed |
| WO-1997000249-A1 | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-01-03 | — | — | WO | disclosed |
| WO-1996005186-A1 | THIAZOLIDINEDIONE DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-02-22 | — | — | WO | disclosed |
| EP-0612743-A1 | Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319637-A1 | 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME | CBR1, CYP1B1, CYP2F1 | ALDH1A3 1744/4885ALDH1A1 160/4885KDM4E 3266/4885 |
| US-20060094874-A1 | Novel substituted aryl alkenoic acid heterocyclic amides | FABP1, LIPC, FABP2 | ALDH1A3 288/4885ALDH1A1 55/4885KDM4E 1636/4885 |
| US-20030161860-A1 | Novel substituted aryl alkenoic acid heterocyclic amides | FABP1, LIPC, FABP2 | ALDH1A3 288/4885ALDH1A1 55/4885KDM4E 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.